Ready For A Wake-up Call - Avis employé Specialty Representative Merck

4,0
2 mai 2009
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great name to have on resume. As a specialty rep given autonomy to run territory how I saw fit. Your experience will heavily depend on your relationship with the district manager. Work life balance was relatively easy to maintain. At a time when access to doctor's offices is decreasing, having Merck on your badge is helpful in breaking through the clutter. Merck science still respected by physicians which helps in telling your story. Deal with SP might breathe new life into the firm Dick Clark has decreased company's reliance solely on Merck R&D and has allowed the firm to think more creatively about ways to develop/acquire new compounds.

Inconvénients

The company's pipeline is dry and blockbusters are heading off patent which threatens the future stability of the firm. Sweeping changes to access in offices and customer interaction will make it increasingly difficult to grow sales. On specialty side, management had difficulty creating compensation model that placed all territories on equal ground. Disconnect exists between marketing and sales. Much of the marketing staff didn't have time in the field so their brand strategies did not always lead to successful sales strategies. Some trainings were a waste of time.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout